Gastric Carcinoma — Trials

Gastric Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

586 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 183
Recruiting: 93
Ph III recruiting: 15
Growth YoY: +4.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (65)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04650451	Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors	suspended	Phase 1	220	Bellicum PharmaceuticalsINDUSTRY	1	Apr 20, 2023	clinicaltrials

Data updated 22 days agoSource updated Apr 20, 2023source: clinicaltrials